Cargando…
Posttreatment Downregulation of Type III Interferons in Patients with Acute Brucellosis
There is a limited number of clinical studies on interferon (IFN) levels in human brucellosis. The novel group of interferons, type III interferons, which consists of four IFN-λ (lambda) molecules called IFN-λ1 or interleukin-29 (IL-29), IFN-λ2 or IL-28A, IFN-λ3 or IL-28B, and IFN-λ4, is not fully k...
Autores principales: | Shokri, Mehran, Khonakdar, Oreinab Ghaffari, Mohammadnia-Afrouzi, Mousa, Sadeghi-Haddad-Zavareh, Mahmoud, Hasanpour, Amirhossein, Barary, Mohammad, Ebrahimpour, Soheil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313358/ https://www.ncbi.nlm.nih.gov/pubmed/34335092 http://dx.doi.org/10.1155/2021/8601614 |
Ejemplares similares
-
C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients
por: Sadeghi-Haddad-Zavareh, Mahmoud, et al.
Publicado: (2021) -
Pathophysiology and Management of Tongue Involvement in COVID-19 Patients
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2022) -
Comparing the outcomes of treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) among COVID-19 inpatients
por: Seyfi, Shahram, et al.
Publicado: (2021) -
Human brucellosis: An overview
por: Hasanjani Roushan, Mohammad Reza, et al.
Publicado: (2015) -
Different Clinical Presentations of Brucellosis
por: Hasanjani Roushan, Mohammad Reza, et al.
Publicado: (2016)